Eric Bjornholt
Analyst · Ambrish Srivastava. Sir, your line is open
Thank you and good afternoon, everyone. During the course of this conference call, we will be making projections and other forward-looking statements regarding future events or the future financial performance of the company. We wish to caution you that such statements are predictions and that actual events or results may differ materially. We refer you to our press releases of today as well as our recent filings with the SEC that identify important risk factors that may impact Microchip's business and results of operations.In attendance with me today are Steve Sanghi, Microchip's Chairman and CEO and Ganesh Moorthy, Microchip's President and COO. I will comment on our fourth quarter and full fiscal year 2020 financial performance. And Steve and Ganesh will then give their comments on the results and discuss the current business environment as well as our guidance. We will then be available to respond to specific investor and analyst questions.We are including information in our press release and in this conference call on various GAAP and non-GAAP measures. We have posted a full GAAP to non-GAAP reconciliation on the Investor Relations page of our website at www.microchip.com, which we believe you will find useful when comparing our GAAP and non-GAAP results. We have also posted a summary of our outstanding debt and our leverage metrics on our website.I will now go through some of the operating results including net sales, gross margin and operating expenses. Other than net sales, I will be referring to these results on a non-GAAP basis, which is based on expenses prior to the effects of acquisition activities, share based compensation and certain other adjustments as described in our press release.I will now go through some the operating results including net sales, gross margin and operating expenses. Other than net sales, I will be referring to these results on a non-GAAP basis, which is based on expenses prior to the effects of acquisition activities, share-based compensation and certain other adjustments as described in our press release.Net sales in the March quarter were $1.326 billion which was up 3% sequentially and above our revised guidance for March 02, 2020, but net sales were expected to be about flat sequentially. We've posted a summary of our GAAP net sales as well as end market demand by product line and geography on our website for your reference.On a non-GAAP basis, gross margins were strong at 62%, operating expenses were at 25.4% and operating income was 36.6% compared to 35.1% in the previous quarter. Non-GAAP net income was $375.5 million, non-GAAP earnings per share was $1.46, which was up significantly from $1.32 for this in the prior quarter. On a GAAP basis in the March quarter, gross margins were 61.4% and include the impact of $5.1 million of share-based compensation and $3.3 million of COVID19 shelter in place restrictions on manufacturing activities, total operating expenses were $653.2 million and include acquisition intangible amortization of $248.5 million special charges of $17.2 million, $15.3 million of acquisition related and other costs and share based compensation of $35.6 million.The GAAP net income was $99.9 million or $0.39 per diluted share. At March quarter GAAP tax benefit was impacted by a variety of factors including tax reserve releases associated with the statute of limitations expiring, deferred tax adjustments related to intercompany movement of intellectual property, tax reserve releases associated with tax audits and other matters.For fiscal year 2020 net sales were $5.274 billion. On a non-GAAP basis gross margin were a record 61.9%, operating expenses were 25.7% of sales and operating income was 36.2% of sales. Non-GAAP net income was $1.44 billion and EPS was $5.62 per diluted share. On a GAAP basis gross margins were 61.5%, operating expenses were 49.2% of sales and operating income was 12.3% of sales. Net income was $570.6 million and EPS was $2.23 per diluted share.The non-GAAP cash tax rate was 7% in the March quarter and 6.3% for fiscal year 2020. We expect our non-GAAP cash tax rate for fiscal '21 to be between 6% and 7% exclusive of the transition tax, any potential tax associated with the restructuring, with the Microsemi operations in the Microchip's global structure and tax audit settlements related to taxes accrued in prior fiscal years.We have many tax attributes and net operating losses and tax credits as well as US interest deductions that we believe will keep our cash tax payments low. The future cash tax payments associated with the transition tax are expected to be about $245 million that we paid over the next six years. We posted a schedule of these projected transition tax payments on the IR page of our website.Our inventory balance at March 31, 2020 was $685.7 million. We had 122 days of inventory at the end of the March quarter down seven days from the prior quarter's level. Inventory at our distributors in the March quarter were at 29 days compared to 28 days at the end of December. We believe distribution inventory levels for Microchip are still quite low compared to historical averages.In the March quarter, we exchanged cash and shares of our common stock to retire $650 million of principal plus accrued interest of out 2025 convertible senior subordinated notes. The cash used to pay the principal on this exchange was funded by 364 day bridge loan. This exchange will significantly reduce your count solution to the extent Microchip stock price appreciates in the future.During the quarter, we also amended our credit facility. As disclosed in our March 21, 2020 press release, the total leverage and senior leverage covenants were favorably modified as part of the amendment giving Microchip greater financial flexibility. The cash flow from operating activities was $371.7 million in the March quarter. As of March 31, the consolidated cash and total investment position was $403 million. We paid down $236 million of total debt in the March quarter.Over the last seven full quarters since we closed the Microsemi acquisition and incurred over $8 billion in debt to do so, we've paid down $2.222 billion of debt and continue to allocate substantially all of our excess cash beyond dividends to aggressively bring down the debt. We've accomplished this despite the adverse macro and market conditions during most of this period, which we feel is a testimony to the cash generation capabilities of our businesses as well as our ongoing operating discipline.We continue to expect our debt levels to reduce significantly over the next several years. Our adjusted EBITDA in the March quarter was $548.1 million and our trailing 12 month adjusted EBITDA was $2.129 billion. Our net debt to adjusted EBITDA excluding our very long dated convertible debt that matures in 2037 and is more equity like in nature was $4.46 at March 31, 2020 and our dividend payment in the March quarter was $88 million.Capital expenditures were $11.9 million in the March quarter and $67.6 million for fiscal year 2020. We expect between $12 million and $18 million in capital spending in the June quarter and overall capital expenditures for fiscal '21 to be between $50 million and $70 million. We continue to add capital to maintain and operate our internal manufacturing operations, support the production capabilities for our new products and technologies as well as to selectively bring in house some of the assembly and test operations that are currently outsourced.We expect these capital investments will bring some gross margin improvement to our business, particularly for the outsourced Atmel and Microsemi manufacturing activities that we are bringing into our own factories. Depreciation expense in the March quarter was $41.8 million.I will now turn it over to Ganesh to give his comments on the performance of the business in the March quarter. Ganesh.